Tonometer

In addition, the World Health Organization (WHO) reported that the current prevalence of glaucoma is causing bilateral blindness in more than 8 million individuals. This figure is expected to increase to over 11 million by 2020 unless effective treatment strategies and improved screening are implemented.
input:
output:We at Keeler, a company that is a leader in the field of Tonometry and has a history of producing high-quality tonometers, are confident that we play a critical role in the detection of Glaucoma by providing the highest quality products at affordable prices to all clinicians worldwide.

Keeler’s most recent Tonometer was developed to account for the diverse environments that clinicians encounter worldwide. The device’s portability, compact design, and long-lasting battery make it suitable for use in a small practice room, domiciliary use, or even large-scale screening programs. Nevertheless, our primary objectives, which we anticipate will be instrumental in enhancing the detection rates of glaucoma, were as follows: – input:
output:Precision:The Tonocare has undergone a rigorous testing protocol in order to provide a direct comparison to GAT. Users will be able to confidently monitor changes in IOP over time as a result of the tonometer’s ability to produce accurate and consistent measurements, which is facilitated by the substantial investment in dynamic puff control.input:
output:Cost-effectiveness:Our objective was to guarantee that the device could be used by all clinicians worldwide without imposing significant costs on their practices or patients. This would inevitably result in an increase in the detection of the second most common cause of blindness.